5 months ago
GILD
AnalystsJames ShinJames Shin's Stock Forecasts
AnalystsJames Shin
Sectors:
Industries:
Analyst Ranking
Top 34%
#1669 out of 4939 analysts
Average Return
+10.88%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
James Shin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +111.87% | $14.74 | $31.23 | 2023-11-08 - 2024-02-09 | Strong Buy |
Sutro Biopharma IncSTRO | +94.67% | $2.25 | $4.38 | 2023-11-08 - 2024-11-08 | Strong Buy |
Immatics NvIMTX | +18.87% | $5.14 | $6.11 | 2025-05-27 - 2025-07-14 | Strong Buy |
Autolus Therapeutics PLCAUTL | +6.88% | $3.49 | $3.73 | 2023-11-08 - 2024-11-08 | Strong Buy |
Gilead Sciences IncGILD | +6.50% | $105.25 | $112.09 | 2025-02-17 - 2025-07-14 | Strong Buy |
James Shin Analyst Color
Get additional color on James Shin's coverage of popular stocks
5 months ago
MRK
8 months ago
LLY
9 months ago
LLY
a year ago
LLY
2 years ago
LLY
James Shin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immatics NvIMTX | 1 | Strong Buy | $10.00 | +63.67% | Initiates Coverage On | 2 months ago |
Gilead Sciences IncGILD | 2 | Strong Buy | $120.00 | +7.06% | Upgrades | 5 months ago |
Merck & Co IncMRK | 2 | Hold | $105.00 | +25.49% | Downgrades | 5 months ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $1,015.00 | +26.98% | Maintains | 8 months ago |
Amgen IncAMGN | 2 | Hold | $305.00 | +2.68% | Reiterates | a year ago |
Incyte CorpINCY | 2 | Hold | $60.00 | -14.26% | Maintains | a year ago |
Bristol Myers Squibb CoBMY | 3 | Hold | $45.00 | -4.94% | Maintains | a year ago |
Legend Biotech CorpLEGN | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Abbvie IncABBV | 1 | Hold | $150.00 | N/A | Initiates Coverage On | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Hold | $800.00 | N/A | Initiates Coverage On | 2 years ago |
Immunogen IncIMGN | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $70.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.